This tutorial review provides an outlook on nanomaterials that are currently being used for
theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor
prognosis. The incidence of HCC and HCC-related deaths have increased over the last …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …

Hepatic malignancies remain a global challenge. Hepatocellular carcinoma (HCC) accounts
for around 90% of patients with liver cancer and is the sixth most common neoplasm …

Cancer is one of the diseases with high mortality worldwide. Various methods for cancer
treatment are being developed, and among them, magnetically driven microrobots capable …

Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death
worldwide. Analogous to the border customs, liver mainly functions as a filter to detoxify …

Hepatocellular carcinoma (HCC), due to the lack of efficient diagnostic methods and short of
available treatments, becomes the third main cause of cancer deaths. Novel treatments for …

BACKGROUND & AIMS: The current standard treatment for advanced hepatocellular
carcinoma (HCC) is sorafenib. This drug is effective but generally does not induce tumor …

Genistein (Gen) is one of the most potent soy isoflavones used for hepatocellular carcinoma
(HCC) treatment. Low aqueous solubility and first-pass metabolism are the main obstacles …